4/A//SEC Filing
Biostage, Inc. 4/A
Accession 0001144204-16-103868
$HRGNCIK 0001563665operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 12:08 PM ET
Size
5.7 KB
Accession
0001144204-16-103868
Insider Transaction Report
Form 4/AAmended
Biostage, Inc.BSTG
Robinson Thomas H
Director
Transactions
- Purchase
Common Stock
2016-05-19$1.36/sh+18,000$24,401→ 18,000 total
Footnotes (2)
- [F1]This report is being filed to amend the footnote description contained in a Form 4 pertaining to the above transaction, filed on 5/20/2016. The description contained in that Form 4 filing incorrectly described the transaction as a sale instead of a purchase of shares.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.315 to $1.38, inclusive. The reporting person undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001563665
Filing Metadata
- Form type
- 4/A
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 12:08 PM ET
- Size
- 5.7 KB